In preclinical studies, GIPR/GLP-1R co-agonism produces less nauseating effects compared to GLP-1R agonism alone as measured by kaolin intake in mice and rats and emetic events in musk shrews (69)
Injected GLP-1 drugs have shown weight loss of around 15 to 20 percent
In the UK, adults with confirmed B12 deficiency and neurological symptoms typically receive hydroxocobalamin injections1 mg intramuscularly on alternate days until symptoms stabilise, followed by maintenance doses every two months
Studies say glutathione can protect against a wide range of health problems, including: alcoholism, Alzheimer's disease, asthma, atherosclerosis, autism, cataracts, chronic fatigue syndrome, colitis, diabetes, glaucoma, heart disease, hepatitis, high cholesterol, liver disease, osteoarthritis, Lyme disease, and Parkinson's disease
The twice-daily group showed 34% higher IGF-1 AUC and 22% greater lean mass gains